rilpivirine
Rilpivirine, sold under the brand name Edurant among others, is a medication, developed by Tibotec, used for the treatment of HIV/AIDS. It is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) with higher potency, longer half-life and reduced side-effect profile compared with older NNRTIs such as efavirenz.
Key facts
- Drug.PDB_ligand
- T27
- Drug.synonyms
- TMC278
- Drug.Verifiedfields
- changed
- Drug.Watchedfields
- changed
- Drug.verifiedrevid
- 417509820
- Drug.image
- Rilpivirine.svg
- Drug.image_class
- skin-invert-image
- Drug.width
- 180
- Drug.image2
- Rilpivirine 3D 2zd1.png
- Drug.image_class2
- bg-transparent
- Drug.tradename
- Edurant, Rekambys, others
- Drug.MedlinePlus
- a611037
- Drug.DailyMedID
Article
11 sectionsContents
- Medical uses
- Available forms
- Contraindications and interactions
- Adverse effects
- Pharmacology
- Mechanism of action
- Pharmacokinetics
- Fixed-dose combinations
- Chemistry
- History
- References
{{Infobox drug | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 417509820 | image = Rilpivirine.svg | image_class = skin-invert-image | width = 180 | alt = | image2 = Rilpivirine 3D 2zd1.png | image_class2 = bg-transparent | alt2 =
| tradename = Edurant, Rekambys, others | Drugs.com = | MedlinePlus = a611037 | DailyMedID = Rilpivirine | pregnancy_AU = B1 | pregnancy_category = | routes_of_administration = By mouth, intramuscular | ATC_prefix = J05 | ATC_suffix = AG05 | ATC_supplemental = combinations:
Connections
Categories
Chemical articles with multiple CAS registry numbersChemical articles with multiple ChEBIsChemical articles with multiple PubChem CIDsChemicals using indexlabelsDrugboxes which contain changes to verified fieldsDrugboxes which contain changes to watched fieldsDrugs developed by Johnson & JohnsonDrugs with non-standard legal statusECHA InfoCard ID from WikidataMultiple chemicals in Infobox drugNitriles